FrancophonIA/ELRC3.0 huggingface dataset:
English: An increase in heparin dose during haemodialysis is frequently required during the course of therapy with epoetin alfa as a result of the increased packed cell volume.
Danish: En øget heparindosis under hæmodialyse kan ofte være nødvendigt ved behandling med epoetin alfa pga. den øgede hæmatokritværdi.
English: Additional supportive care should be provided as necessary.
Danish: Hvis det er påkrævet, bør der desuden gives understøttende behandling.
English: 20,000 IU/0.5 mL 30,000 IU/0.75 mL 40,000 IU/1 mL
Danish: 20.000 IE/0,5 ml 30.000 IE/0,75 ml 40.000 IE/1 ml
English: Epoetin alfa should be used with caution in patients with porphyria.
Danish: Epoetin alfa bør anvendes med forsigtighed til patienter med porfyri.
English: Epoetin alfa HEXAL is prescribed to stimulate your bone marrow to produce more red blood cells.
Danish: Epoetin alfa HEXAL ordineres for at stimulere din knoglemarv til at danne flere røde blodlegemer.
English: After injecting the liquid, remove the needle and let go of your skin.
Danish: Efter indsprøjtning af væsken trækkes kanylen ud, og du kan nu slippe huden.
English: The effect of epoetin alfa (300 IU/kg or 100 IU/kg) on the exposure to allogeneic blood transfusion has been evaluated in a placebo-controlled, double-blind clinical trial in non-iron deficient adult patients scheduled for major elective orthopaedic hip or knee surgery.
Danish: Virkningen af epoetin alfa (300 IE/kg eller 100 IE/kg) på at blive udsat for en allogen blodtransfusion er blevet evalueret i et placebokontrolleret, dobbeltblindet klinisk studie hos voksne patienter uden jernmangel, som var planlagt til en større elektiv ortopædkirurgisk operation af hofte eller knæ.
English: Additional studies compared the 40,000 IU once-weekly regimen of epoetin alfa with biweekly doses ranging from 80,000 to 120,000 IU subcutaneously.
Danish: Yderligere studier sammenlignede et behandlingsprogram med 40.000 IE epoetin alfa én gang ugentligt med doser i intervallet fra 80.000-120.000 IE subkutant hver anden uge.
English: You may still be able to use Epoetin alfa HEXAL, but discuss it with your doctor first.
Danish: Det kan være, at det stadig er muligt at bruge Epoetin alfa HEXAL, men du skal først tale med lægen om det.
English: • epileptic seizures or fits;
Danish: • epilepsi eller krampeanfald,
English: Anaphylactic reaction3
Danish: Anafylaktisk reaktion3
English: If you are a patient with chronic renal failure, and particularly if you do not respond properly to Epoetin alfa HEXAL, your doctor will check your dose of Epoetin alfa HEXAL because repeatedly increasing your dose of Epoetin alfa HEXAL if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death.
Danish: Hvis du har kronisk nyreinsufficiens, og især hvis du ikke reagerer korrekt på Epoetin alfa HEXAL, vil din læge kontrollere din Epoetin alfa HEXAL-dosis, da du har større risiko for at få et problem med hjertet eller blodkarrene, hvis din Epoetin alfa HEXAL-dosis skal øges gentagne gange, fordi du ikke reagerer på behandlingen.
English: If partial use of a syringe is required, remove unwanted solution before injection.
Danish: Hvis dosis kun kræver en del af indholdet, fjernes den overflødige mængde af opløsningen før indsprøjtning.
English: Epoetin alfa HEXAL is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).
Danish: Epoetin alfa HEXAL anvendes til at behandle anæmi hos voksne med en knoglemarvssygdom, der medfører svære forstyrrelser i dannelsen af blodlegemer (myelodysplastiske syndromer).
English: Baseline Characteristics for Subjects with sEPO < 200 mU/mL at Screening
Danish: Karakteristika ved baseline for forsøgspersoner med sEPO < 200 mE/ml ved screening Randomiseret
English: Paediatric patients with very low initial haemoglobin (< 6.8 g/dL or < 4.25 mmol/L) may require higher maintenance doses than patients whose initial haemoglobin is higher (> 6.8 g/dL or > 4.25 mmol/L).
Danish: Pædiatriske patienter med meget lavt initialt hæmoglobin (< 6,8 g/dl eller < 4,25 mmol/l) kan have behov for større vedligeholdelsesdoser end patienter, som har et højere hæmoglobin initialt (> 6,8 g/dl eller > 4,25 mmol/l).
English: • high blood pressure;
Danish: • forhøjet blodtryk,
English: - The other ingredients are: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, sodium chloride, glycine, polysorbate 80, hydrochloric acid (for pH-adjustment), sodium hydroxide (for pH-adjustment), and water for injections.
Danish: - Øvrige indholdsstoffer: natriumdihydrogenphosphatdihydrat, dinatriumphosphatdihydrat, natriumchlorid, glycin, polysorbat 80, saltsyre (til justering af pH-værdien), natriumhydroxid (til justering af pH-værdien) og vand til injektionsvæsker.
English: In cases where there is a medical need to shorten the lead time before surgery to less than three weeks, Epoetin alfa HEXAL 300 IU/kg should be administered subcutaneously daily for 10 consecutive days prior to surgery, on the day of surgery and for four days immediately thereafter.
Danish: I tilfælde, hvor der er en klinisk årsag til at afkorte behandlingstiden før operationen til mindre end tre uger, skal Epoetin alfa HEXAL 300 IE/kg administreres subkutant dagligt i 10 dage før operationen, på selve operationsdagen samt i de 4 første dage umiddelbart efter operationen.
English: Therefore, epoetin alfa should not be used in patients with baseline haemoglobin > 13 g/dL (> 8.1 mmol/L).
Danish: Derfor bør epoetin alfa ikke anvendes til patienter med et baseline-hæmoglobinkoncentration på > 13 g/dl (> 8,1 mmol/l).
English: Only take one dose of Epoetin alfa HEXAL from each syringe.
Danish: Tag kun en dosis af Epoetin alfa HEXAL fra hver sprøjte.
English: Patients should be monitored closely to ensure that the lowest approved dose of Epoetin alfa HEXAL is used to provide adequate control of anaemia and of the symptoms of anaemia.
Danish: Patienterne skal monitoreres nøje for at sikre, at der anvendes den laveste godkendte Epoetin alfa HEXAL-dosis til at opnå tilstrækkelig kontrol med anæmi og symptomerne på anæmi.
English: * Produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology For the full list of excipients, see section 6.1.
Danish: * Fremstillet ved rekombinant DNA-teknologi i celler fra kinesiske hamstres ovarier (CHO).
English: Epoetin alfa HEXAL may be given by injection:
Danish: Epoetin alfa HEXAL kan gives som en indsprøjtning:
English: Do not freeze or shake.
Danish: Må ikke nedfryses eller omrystes.
English: The half-life of epoetin alfa following multiple dose intravenous administration is approximately 4 hours in healthy subjects.
Danish: Halveringstiden af epoetin alfa efter gentagne intravenøse doser er ca. 4 timer hos raske personer.
English: The safety and efficacy of epoetin alfa in chronic renal failure patients with anaemia before initiation of dialysis or on peritoneal dialysis have not been established.
Danish: Epoetin alfas sikkerhed og virkning hos patienter med kronisk nyreinsufficiens med anæmi før påbegyndelse af dialyse eller i peritonealdialyse er ikke klarlagt.
English: In these trials, epoetin alfa administered 3 times per week and once weekly has been shown to increase haemoglobin and decrease transfusion requirements after the first month of therapy in anaemic cancer patients.
Danish: Disse studier viste, at epoetin alfa, der administreres 3 gange ugentligt og én gang ugentligt, øger hæmoglobin og reducerer behovet for transfusioner efter den første måneds behandling hos anæmiske cancerpatienter.
English: - decreased locoregional control in patients with advanced head and neck cancer receiving radiation therapy when administered to achieve a haemoglobin concentration level of greater than 14 g/dL (8.7 mmol/L),
Danish: - reduceret lokoregional kontrol hos patienter med fremskreden hoved- og halscancer, som får strålebehandling, når stofferne administreres for at opnå en hæmoglobinkoncentration, som er højere end 14 g/dl (8,7 mmol/l),
English: Excipients: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, sodium chloride, glycine, polysorbate 80, hydrochloric acid (for pH-adjustment), sodium hydroxide (for pH-adjustment), and water for injections.
Danish: Hjælpestoffer: natriumdihydrogenphosphatdihydrat, dinatriumphosphatdihydrat, natriumchlorid, glycin, polysorbat 80, saltsyre (til justering af pH), natriumhydroxid (til justering af pH), vand til injektionsvæsker.
English: Chronic renal failure patients being treated with epoetin alfa should have haemoglobin levels measured on a regular basis until a stable level is achieved, and periodically thereafter.
Danish: Hos patienter med kronisk nyresvigt, der behandles med epoetin alfa, bør hæmoglobinniveauet måles regelmæssigt, indtil der opnås et stabilt niveau, og derefter periodisk.
English: Epoetin alfa HEXAL is used in moderately anaemic adults about to have major orthopaedic surgery (for example hip or knee replacement operations), to reduce the potential need for blood transfusions.
Danish: Epoetin alfa HEXAL anvendes til voksne med moderat anæmi, som skal have foretaget en større ortopædkirurgisk operation (for eksempel udskiftning af hofte eller knæ), for at nedsætte det eventuelle behov for blodtransfusioner.
English: Anti-erythropoietin antibody positive
Danish: Anti-erytropoietin-antistofpositiv
English: In the double-blind study, patients were treated with epoetin alfa 600 IU/kg or placebo intravenously once daily every 3 to 4 days over 3 weeks (total 6 doses).
Danish: I det dobbeltblindede studie blev patienterne behandlet med epoetin alfa 600 IE/kg eller placebo intravenøst én gang dagligt hver 3. til 4. dag i løbet af 3 uger (i alt 6 doser).
English: Epoetin alfa administered 3 times per week or once weekly has been shown to increase haemoglobin and decrease transfusion requirements after the first month of therapy in anaemic cancer patients receiving chemotherapy.
Danish: Det er vist, at administration af epoetin alfa 3 gange ugentligt eller én gang ugentligt øger hæmoglobin og reducerer behovet for transfusioner efter den første måneds behandling hos anæmiske cancerpatienter, der får kemoterapi.
English: Epoetin alfa HEXAL is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.
Danish: Epoetin alfa HEXAL anvendes til at behandle anæmi hos voksne, som får kemoterapi for solide svulster, ondartet lymfom eller myelomatose (knoglemarvskræft), og som kan have et behov for en blodtransfusion.
English: If you forget to use Epoetin alfa HEXAL
Danish: Hvis du har glemt at tage Epoetin alfa HEXAL
English: - Uncontrolled hypertension.
Danish: - Hypertension, der er svær at regulere.
English: Do not throw away any medicines via wastewater or household waste.
Danish: Smid ikke anvendt lægemiddel samt affald heraf ud.
English: Caution should be exercised with escalation of Epoetin alfa HEXAL doses in patients with chronic renal failure.
Danish: Der skal udvises forsigtighed, når Epoetin alfa HEXAL-dosis øges hos patienter med kronisk nyreinsufficiens.
English: The pre-filled syringes are ready to use (see section 4.2).
Danish: De fyldte injektionssprøjter er klar til brug (se pkt.
English: - shortened overall survival and increased deaths attributed to disease progression at 4 months in patients with metastatic breast cancer receiving chemotherapy when administered to achieve a haemoglobin concentration range of 12 to 14 g/dL (7.5 to 8.7 mmol/L),
Danish: - kortere samlet overlevelse og flere dødsfald, som tilskrives sygdomsprogression ved 4 måneder hos patienter med metastatisk brystcancer, som får kemoterapi, når stofferne gives for at opnå en hæmoglobinkoncentration på 12 til 14 g/dl (7,5-8,7 mmol/l),
English: Epoetin alfa HEXAL should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L).
Danish: Epoetin alfa HEXAL bør administreres for at øge hæmoglobin til ikke over 11 g/dl (6,8 mmol/l).
English: The AUCs of the respective pharmacodynamic parameters were similar between the 150 IU/kg, 3 times per week and 40,000 IU, once-weekly dosing regimens in healthy subjects and also in anaemic cancer subjects.
Danish: AUC for de respektive farmakodynamiske parametre var sammenlignelige mellem doseringsprogrammer med 150 IE/kg 3 gange ugentligt og 40.000 IE én gang ugentligt hos raske personer samt hos anæmiske personer med cancer.
English: Inject the Epoetin alfa HEXAL solution as you have been shown by your doctor.
Danish: Indsprøjt Epoetin alfa HEXAL opløsningen efter lægens anvisning.
English: Hypersensitivity reactions, including cases of rash (including urticaria), anaphylactic reactions, and angioneurotic oedema have been reported (see section 4.4).
Danish: Overfølsomhedsreaktioner, herunder tilfælde med udslæt (inklusive urticaria), anafylaktiske reaktioner og angioødem er blevet indberettet (se pkt.
English: 1 Common in dialysis 2 Includes arterial and venous, fatal and non fatal events, such as deep venous thrombosis, pulmonary emboli, retinal thrombosis, arterial thrombosis (including myocardial infarction), cerebrovascular accidents (including cerebral infarction and cerebral haemorrhage) transient ischaemic attacks, and shunt thrombosis (including dialysis equipment) and thrombosis within arteriovenous shunt aneurisms 3 Addressed in the subsection below and/or in section 4.4
Danish: lungeemboli, retinal trombose, arteriel trombose (herunder myokardieinfarkt), cerebrovaskulære hændelser (herunder cerebralt infarkt og cerebral blødning), transitoriske iskæmiske anfald, shunttrombose (inkluderende dialyseudstyret) og trombose i arteriovenøse shunt-aneurismer 3 Behandlet i delafsnittet nedenfor og/eller i pkt.
English: Pre-filled syringes*
Danish: Fyldte sprøjter *
English: In paediatric patients the recommended haemoglobin concentration range is between 9.5 g/dL to 11 g/dL (5.9 to 6.8 mmol/L).
Danish: Hos pædiatriske patienter er det anbefalede koncentrationsinterval for hæmoglobin mellem 9,5 g/dl og 11 g/dl (5,9-6,8 mmol/l).
English: Epoetin alfa HEXAL is not approved in the management of anaemia associated with hepatitis C.
Danish: Epoetin alfa HEXAL er ikke godkendt til behandling af anæmi forbundet med hepatitis C.
English: erythropoietin suggested that distribution volume was approximately 1.5 to 2 times higher in the preterm neonates than in the healthy adults, and clearance was approximately 3 times higher in the preterm neonates than in healthy adults.
Danish: Et studie med 7 for tidligt fødte nyfødte med lav fødselsvægt og 10 raske voksne, der fik erythropoietin intravenøst indikerede, at fordelingsvolumen var ca. 1,5 til 2 gange højere hos de for tidligt fødte nyfødte end hos de raske voksne, og clearance var ca. 3 gange højere hos de for tidligt fødte nyfødte end hos de raske voksne.
English: Due to intra-patient variability, occasional individual haemoglobin concentrations for a patient above and below the desired haemoglobin concentration range may be observed.
Danish: På grund af variabilitet hos den enkelte patient kan der af og til observeres individuelle koncentrationniveauer for hæmoglobin for en patient, som ligger over eller under det ønskede koncentrationsinterval for hæmoglobin.
English: • The usual dose is 600 IU per kilogram body weight twice a week.
Danish: • Den sædvanlige dosis er 600 IE pr. kilo kropsvægt 2 gange om ugen.
English: In the single-blind study, patients were treated with epoetin alfa 300 IU/kg or 600 IU/kg or placebo intravenously once daily every 3 to 4 days over 3 weeks (total 6 doses).
Danish: I det enkeltblindede studie blev patienterne behandlet med epoetin alfa 300 IE/kg eller 600 IE/kg eller placebo intravenøst én gang dagligt hver 3. til 4. dag i løbet af 3 uger (i alt 6 doser).
English: Epoetin alfa HEXAL contains sodium
Danish: Epoetin alfa HEXAL indeholder natrium
English: Based on information available to date, correction of anaemia with epoetin alfa in adult patients with renal insufficiency not yet undergoing dialysis does not accelerate the rate of progression of renal insufficiency.
Danish: Ifølge foreliggende oplysninger øger epoetin alfa-behandlingen af anæmi hos voksne patienter med nyreinsufficiens, der endnu ikke er i dialyse, ikke progressionshastigheden for nyreinsufficiens.
English: Epoetin alfa should be used with caution in patients with chronic liver failure.
Danish: Epoetin alfa bør anvendes med forsigtighed hos patienter med kronisk leversvigt.
English: Epoetin alfa is not approved in the management of anaemia associated with hepatitis C.
Danish: Epoetin alfa er ikke godkendt til behandling af anæmi forbundet med hepatitis C.
English: The safety of epoetin alfa has not been established in patients with hepatic dysfunction.
Danish: Epoetin alfas sikkerhed er ikke blevet klarlagt hos patienter med leverdysfunktion.
English: Due to intra-patient variability, occasional individual haemoglobin values for a patient above and below the desired haemoglobin concentration range may be observed.
Danish: På grund af variabilitet hos den enkelte patient kan der af og til observeres individuelle hæmoglobinværdier, som ligger over eller under det ønskede koncentrationsinterval for hæmoglobin, hos en patient.
English: If necessary, increase or decrease the dose by 25 IU/kg (3 times per week) until the desired haemoglobin concentration range of between 9.5 g/dL to 11 g/dL (5.9 to 6.8 mmol/L) is achieved (this should be done in steps of at least four weeks).
Danish: Hvis det er nødvendigt, øges eller mindskes dosis med 25 IE/kg (3 gange ugentligt), indtil det tilstræbte koncentrationsinterval for hæmoglobin på mellem 9,5 g/dl og 11 g/dl (5,9-6,8 mmol/l) er opnået (dette bør ske med intervaller på mindst 4 uger).
English: Patients with very low initial haemoglobin (< 6 g/dL or < 3.75 mmol/L) may require higher maintenance doses than patients whose initial anaemia is less severe (> 8 g/dL or > 5 mmol/L).
Danish: Patienter med en meget lav initial hæmoglobinværdi (< 6 g/dl eller < 3,75 mmol/l) kan have behov for en større vedligeholdelsesdosis end patienter, hvis initiale hæmoglobinværdier er højere (> 8 g/dl eller > 5,0 mmol/l).
English: Epoetin alfa HEXAL should not be used:
Danish: Epoetin alfa HEXAL må ikke anvendes:
English: In patients with a poor haemoglobin response to Epoetin alfa HEXAL, alternative explanations for the poor response should be considered (see section 4.4 and 5.1).
Danish: Hos patienter med et dårligt hæmoglobinrespons på Epoetin alfa HEXAL skal alternative forklaringer på det dårlige respons (se pkt.
English: Some patients with more extended dosing intervals (greater than once weekly) of epoetin alfa may not maintain adequate haemoglobin levels (see section 5.1) and may require an increase in epoetin alfa dose.
Danish: Nogle patienter med mere udvidede doseringsintervaller (længere end én gang ugentligt) af epoetin alfa vil måske ikke opretholde tilstrækkelige hæmoglobinniveauer (se pkt.
English: An increased incidence of thrombotic vascular events (TVEs) has been observed in patients receiving ESAs (see section 4.4).
Danish: En højere forekomst af trombotiske vaskulære hændelser (TVE'er) er blevet observeret hos patienter, der får ESA'er (se pkt.
English: Median overall survival in the epoetin alfa plus SOC group was 17.8 months compared with 18.0 months in the SOC alone group (HR 1.07, 95% CI: 0.97, 1.18).
Danish: Den samlede middeloverlevelse i epoetin alfa plus standardbehandlingsgruppen var 17,8 måneder sammenlignet med 18,0 måneder i den rene standardbehandlingsgruppe (HR 1,07, 95% KI: 0,97, 1,18).
English: What you need to know before you use Epoetin alfa HEXAL
Danish: Det skal du vide, før du begynder at tage Epoetin alfa HEXAL
English: Particular attention should be paid to sudden stabbing migraine-like headaches as a possible warning signal (see section 4.4).
Danish: Der bør udvises særlig opmærksomhed over for pludseligt indsættende stikkende, migrænelignende hovedpine, da dette kan være et muligt forvarselstegn (se pkt.
English: Cancer patients being treated with epoetin alfa should have haemoglobin levels measured on a regular basis until a stable level is achieved, and periodically thereafter.
Danish: Hæmoglobinniveauet bør måles regelmæssig hos cancerpatienter, der bliver behandlet med epoetin alfa, indtil der opnås et stabilt niveau, og derefter periodisk.
English: The incidence of bone marrow fibrosis was not increased in a study of haemodialysis patients who were treated with epoetin alfa for 3 years compared to a matched control group of dialysis patients who had not been treated with epoetin alfa.
Danish: I et studie med hæmodialysepatienter, der blev behandlet med epoetin alfa i tre år, var forekomsten af knoglemarvsfibrose ikke højere end hos kontrolgruppens dialysepatienter, der ikke blev behandlet med epoetin alfa.
English: Dose hold and decrease: Epoetin alfa should be withheld when the haemoglobin concentration exceeds 12 g/dL (7.5 mmol/L).
Danish: Opretholdelse og reduktion af dosis: Epoetin alfa skal seponeres, når hæmoglobinkoncentrationen overstiger 12 g/dl (7,5 mmol/l).
English: Epoetin alfa HEXAL should be administered by the intravenous route.
Danish: Epoetin alfa HEXAL skal administreres intravenøst.
English: Instructions on how to inject Epoetin alfa HEXAL yourself
Danish: Vejledninger i, hvordan du selv skal indsprøjte Epoetin alfa HEXAL
English: If necessary, increase or decrease the dose by 25 IU/kg (3 times per week) until the desired haemoglobin concentration range between 10 g/dL to 12 g/dL (6.2 to 7.5 mmol/L) is achieved (this should be done in steps of at least four weeks).
Danish: Hvis det er nødvendigt, øges eller mindskes dosis med 25 IE/kg (3 gange ugentligt), indtil det tilstræbte koncentrationsinterval for hæmoglobin mellem 10 g/dl og 12 g/dl (6,2-7,5 mmol/l) er opnået (dette bør ske ved intervaller på mindst 4 uger).
English: The median time to progression (TTP) based on investigator-determined progressive disease (PD) was 7.5 months in the epoetin alfa plus SOC group and 7.5 months in the SOC group (HR 1.099, 95% CI: 0.998, 1.210).
Danish: Mediantiden til progression (TTP) pr. investigatorvurdering af progredieret sygdom (PD) var 7,5 måneder i epoetin alfa plus standardbehandlingsgruppen og 7,5 måneder i standardbehandlingsgruppen (HR 1,099, 95% KI: 0,998, 1,210).
English: • The recommended dose is 600 IU per kilogram body weight once a week.
Danish: • Den anbefalede dosis er 600 IE pr. kilogram kropsvægt én gang ugentligt.
English: Epoetin alfa exhibits a dose-related effect on haematological parameters which is independent of route of administration.
Danish: Uafhængigt af administrationsvejen udviser epoetin alfa en dosisrelateret virkning på hæmatologiske parametre.
English: Epoetin alfa HEXAL contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”.
Danish: Epoetin alfa HEXAL indeholder mindre end 1 mmol (23 mg) natrium pr. dosis, det vil sige, den er i det væsentlige natriumfri.
English: Uncommon side effects These may affect up to 1 in 100 people.
Danish: Ikke almindelige bivirkninger Disse kan forekomme hos op til 1 ud af 100 personer.
English: Epoetin alfa should be used with caution in nursing women.
Danish: Epoetin alfa bør anvendes med forsigtighed hos ammende kvinder.
English: In cancer patients receiving chemotherapy, the 2 to 3 week delay between ESA administration and the appearance of erythropoietin-induced red cells should be taken into account when assessing if epoetin alfa therapy is appropriate (patient at risk of being transfused).
Danish: Når det vurderes, hvorvidt behandling med epoetin alfa er hensigtsmæssig for cancerpatienter i kemoterapibehandling, skal det tages i betragtning, at der går 2-3 uger fra ESA indgives, inden der forekommer erytropoietin-inducerede røde blodlegemer (patienter med risiko for transfusioner).
English: Epoetin alfa HEXAL is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF):
Danish: Epoetin alfa HEXAL er indiceret til behandling af symptomatisk anæmi i forbindelse med kronisk nyreinsufficiens (CRF)